WWTR1 and neoplasm: The oncogene Yes-associated protein (YAP) and its paralogue Transcriptional Co-Activator With PDZ-binding Motif (TAZ or WWTR1) have been considered as attractive pharmacological targets, as they are highly activated in many forms of cancers and contribute to tumor growth and invasion (39).